PE-Backed Nycomed Buys China's Techpool

Swiss drug maker Nycomed has acquired a majority stake in the Chinese pharmaceutical company Guangdong Techpool Bio-Pharma, Reuters reported. Nycomed paid roughly $210 million for a 51.34% stake in the Guangdong-based company. Zurich-based Nycomed is owned by four private equity firms: Nordic Capital, Credit Suisse's DLJ Merchant Banking, Coller International Partners and New York-based Avista Capital Partners.

DealsNorth AmericaUSBriefs